StonvexLoading…
StonvexStonvexStonvexCore line items from ENR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.95B | $2.89B | $2.96B | $3.05B |
Operating Income | $284.10M | $53.80M | $175.70M | $-305.50M |
Net Income | $239.00M | $38.10M | $140.50M | $-231.50M |
EPS (Diluted) | $3.32 | $0.52 | $1.94 | $-3.37 |
Total Assets | $4.56B | $4.34B | $4.51B | $4.57B |
Total Liabilities | $4.39B | $4.21B | $4.30B | $4.44B |
Cash & Equivalents | $236.20M | $216.90M | $223.30M | $205.30M |
Free Cash Flow OCF − CapEx | $63.20M | $331.70M | $338.40M | $-76.80M |
Shares Outstanding | 72.00M | 72.70M | 72.40M | 69.90M |